Document is current
Any future updates will be listed below
-
Authors
Carmona-Maurici, Júlia
Eskubi-Turró, Iratxe
Viñas, Anna
Ricart-Jané, David
López-Tejero, Mª Dolores
Amigó, Núria
Bermúdez, Marcelino
Baena-Fustegueras, Juan Antonio
Peinado-Onsurbe, Julia
Pardina, Eva https://orcid.org/0000-0002-0588-1324
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI15/00190)
Universitat de Barcelona
- License Information
-
More Information
Article History
Received: 24 March 2025
Accepted: 3 September 2025
First Online: 29 October 2025
Declarations
:
: All procedures performed in the studies involving human participants were in accordance with the standards of the ethics committee of Arnau de Vilanova University Hospital “Comitè d’Ètica d’Investigació amb Medicaments, Hospital Universitari Arnau de Vilanova Lleida”, project number "CEIC-1369". Furthermore, they complied with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all patients for being included in the study. No animal studies were carried out by the authors for this article.
: NA is a shareholder of Biosfer Teslab, the company that commercializes the lipoprotein profiling described in the present manuscript, and is one of the authors of the patented method. The other authors have no conflicts of interest.
